Comparing TNF Pharmaceuticals (TNFA) & Its Rivals

Risk and Volatility TNF Pharmaceuticals has a beta of 2.43, suggesting that its stock price is 143% more volatile than the S&P 500. Comparatively, TNF Pharmaceuticals’ rivals have a beta of 1.31, suggesting that their average stock price is 31% more volatile than the S&P 500. Institutional and Insider Ownership 9.6% of TNF Pharmaceuticals shares […]

Leave a Reply

Your email address will not be published.

Previous post AAON (AAON) Expected to Announce Quarterly Earnings on Thursday
Next post Matador Resources (NYSE:MTDR) Now Covered by Analysts at UBS Group